Sign inJoin waitlistJoin the waitlist

VS

Veeral Sheth

Director of Clinical Research, University Retina and Macula Associates · University of Miami/Jackson Health System

Credentials: · · · · ·

History

University Retina and Macula Associates · University of Miami/Jackson Health System
Present

University Of Chicago Hospitals & Clinics
2009–2010
Ophthalmology
University of Illinois College of Medicine at Chicago
2005–2009
West Suburban Hospital Medical Center
2004–2005
University of Illinois College of Medicine
2000–2004

Research

Efficacy and safety of avacincaptad pegol in patients with geographic atrophy (GATHER2): 12-month results from a randomised, double-masked, phase 3 trial
The Lancet · 2023 · 299 citations
The real-world efficacy and safety of faricimab in neovascular age-related macular degeneration: the TRUCKEE study - 6 month results
Eye · 2023 · 157 citations
Three-Year Safety and Efficacy of the 0.19-mg Fluocinolone Acetonide Intravitreal Implant for Diabetic Macular Edema: The PALADIN Study
Ophthalmology · 2022 · 55 citations

AK
Arshad Khanani
10 papers
DE
David Eichenbaum
9 papers
CW
Charles Wykoff
7 papers
CD
Carl Danzig
5 papers
Seenu Hariprasad
4 papers
DP
Dante Pieramici
3 papers
DL
David Lally
3 papers
HB
Harit Bhatt
3 papers
Jared Nielsen
3 papers
JW
Jeffrey Willis
3 papers
Jordan Graff
3 papers
MB
Mark Barakat
3 papers

Clinical trials

A Pivotal Safety and Efficacy Study of OCS-01 Eye Drops in Participants With Diabetic Macular Edema (DIAMOND 1)
Principal investigator · Completed · Phase 2, Phase 3
Oculis
2021–2026
A Study in Adults With Geographic Atrophy
Site PI · Recruiting · Phase 2
Sitala Bio LTD
2026–2029
Single Intravitreal (IVT) Injection of 4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular Degeneration
Site PI · Recruiting · Phase 3
4D Molecular Therapeutics
2025–2029
4D-150 in Patients With Neovascular (Wet) Age-Related Macular Degeneration
Site PI · Recruiting · Phase 1, Phase 2
4D Molecular Therapeutics
2021–2031